Building on proven methodology, STEM AI was developed to provide an even deeper level of insight for organisations looking to ...

The Gilead Foundation has announced a $12m investment in 33 community-based organisations across 14 US states and Washington ...

Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...

Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective ...

Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and ...

CNX Therapeutics, a specialty pharmaceutical company, has appointed Erin Federman as a non-executive director, effective from ...

Can we influence what AI says? The question makes complete sense – especially considering what’s happening at scale. At this ...

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it is applied to ...

UK biotech N4 Pharma, a company developing a gene delivery system to enable advanced therapies for cancer and other diseases, ...

Novo Nordisk has announced it will invest 432m euros in its facility in Ireland. The tabletting facility, in Monksland, ...

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional ...

The US Food and Drug Administration (FDA) has issued draft guidance for sponsors seeking approval for targeted individualised ...